Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Post-Approval Study of Congenital Pulmonic Valve Dysfunction Studying the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System With Alterra Adaptive Prestent

NCT05378386 is registered in ClinicalTrials.gov with Edwards Lifesciences as lead sponsor.

NCT NCT05378386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Post-Approval Study of Congenital Pulmonic Valve Dysfunction Studying the Edwards SAPIEN 3 Transcatheter Pulmonary Valve System With Alterra Adaptive Prestent
Lead sponsor
Edwards Lifesciences
Phase
Observational
Overall status
Active, not recruiting
Start date
May 12, 2022
Completion date
July 31, 2035
Enrollment
150 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

complex congenital heart defect, pulmonary regurgitation, pulmonary valve insufficiency, rvot anomaly, tetralogy of fallot